<DOC>
	<DOCNO>NCT00442897</DOCNO>
	<brief_summary>Evaluate proportion hyperlipaemic person know coronary heart disease achieve ldl-c goal define national cholesterol education program ( NCEP ) adult treatment panel ( ATP ) III guideline</brief_summary>
	<brief_title>Vytorin ( 10/20 Or 10/40 ) Compared Atorvastatin ( 10 mg 20 mg ) Patients With Coronary Artery Disease ( 0653A-126 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Ezetimibe , Simvastatin Drug Combination</mesh_term>
	<criteria>Patients na√Øve lower lipid agent Patients treat lower lipid agent washout period 4 week . Impaired kidney function Increased liver enzyme level Pregnant woman Hypersensitivity ezetimibe statin agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Hypercholesterolaemia</keyword>
</DOC>